Pharmacological approaches to reducing allogeneic blood exposure
Open Access
- 24 January 2003
- journal article
- review article
- Published by Wiley in Vox Sanguinis
- Vol. 84 (1) , 2-10
- https://doi.org/10.1046/j.1423-0410.2003.00258.x
Abstract
This article discusses evidence for the role of pharmacological interventions such as the protease inhibitor aprotinin (Trasylol®), lysine analogue anti‐fibrinolytics [tranexamic acid (Cyclokapron®) ...Keywords
This publication has 61 references indexed in Scilit:
- A comparative study of the postoperative allogeneicblood‐sparing effects of tranexamic acid and of desmopressin after total knee replacementTransfusion, 2001
- Blood conservation with tranexamic acid in total hip arthroplasty: A randomized, double-blind study in 40 primary operationsActa Orthopaedica, 2001
- Tranexamic Acid Reduces Red Cell Transfusion Better than ε-Aminocaproic Acid or Placebo in Liver TransplantationAnesthesia & Analgesia, 2000
- Use of point-of-care test in identification of patients who can benefit from desmopressin during cardiac surgery: a randomised controlled trialThe Lancet, 1999
- Continuous Small-Dose Tranexamic Acid Reduces Fibrinolysis but not Transfusion Requirements During Orthotopic Liver TransplantationAnesthesia & Analgesia, 1997
- Tranexamic Acid Reduces Blood Loss, Transfusion Requirements, and Coagulation Factor Use in Primary Orthotopic Liver TransplantationAnesthesiology, 1996
- The efficacy of single-dose aprotinin 2 million KIU in reducing blood loss and its impact on the incidence of deep venous thrombosis in patients undergoing total hip replacement surgeryJournal of Clinical Anesthesia, 1996
- AprotininDrugs, 1995
- Does Aprotinin Really Reduce Blood Loss in Orthotopic Liver Transplantation?Seminars in Thrombosis and Hemostasis, 1993
- Treatment with Desmopressin Acetate to Reduce Blood Loss after Cardiac SurgeryNew England Journal of Medicine, 1986